Cargando…
Role of IL-9 and STATs in hematological malignancies (Review)
Although interleukin-9 (IL-9) exhibits pleiotropic functions in the immune system, it remains a well-known cytokine in hematological malignancies. Previous cell culture and animal model studies have revealed that the Janus kinase-signal transducer and activator of transcription signaling pathway, wh...
Autores principales: | CHEN, NA, WANG, XIN |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3919939/ https://www.ncbi.nlm.nih.gov/pubmed/24520283 http://dx.doi.org/10.3892/ol.2013.1761 |
Ejemplares similares
-
IL-31, itch and hematological malignancies
por: Di Salvo, Eleonora, et al.
Publicado: (2021) -
The Role of Janus Kinase/STAT3 Pathway in Hematologic Malignancies With an Emphasis on Epigenetics
por: Zeinalzadeh, Elham, et al.
Publicado: (2021) -
Retraction: The role of Janus kinase/STAT3 pathway in hematologic malignancies with an emphasis on epigenetics
Publicado: (2023) -
Role of Wnt canonical pathway in hematological malignancies
por: GE, Xueling, et al.
Publicado: (2010) -
The role of BCL11B in hematological malignancy
por: Huang, Xin, et al.
Publicado: (2012)